FDA Grants Final Approval for Treatment of Cataplexy in Adults With Narcolepsy
The US Food and Drug Administration (FDA) has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy
Read MoreThe US Food and Drug Administration (FDA) has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy
Read MoreINDIANAPOLIS (WISH) — Each week in the United States, almost 70,000 babies are born premature, meaning the child is born
Read MoreOn May 1, 2023, Bausch Health Companies (TSE:BHC) remained firmly embedded in the minds of market analysts following its impressive
Read MoreThis is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring
Read MoreProfessional Research Services (PRS) is a research company located in Troy, Mich. They specialize in conducting peer review surveys of
Read MoreEurope, including Switzerland, has faced worsening drug shortages over the last few years. © Keystone / Christian Beutler Switzerland is
Read MoreEmployees of a Maine restaurant got a surprise when they opened a large wooden crate that they thought was a
Read MoreNcuti Gatwa is set to be the 15th Doctor in Doctor Who, officially taking over as the Doctor in the
Read More…As NIPRD, Bloom, launches project By Doris Obinna Director general/chief executive officer, Institute for Pharmaceutical Research and Development
Read MoreAn ingestible capsule that delivers an electrical current can stimulate the release of the hormone ghrelin. Developed at MIT, the
Read More